AE Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.44M | Sell |
4,866
-484
| -9% | -$232K | 0.01% | 600 |
|
|
2026
Q1 | $2.63M | Buy |
5,350
+93
| +2% | +$50.5K | 0.01% | 569 |
|
|
2025
Q4 | $3.05M | Sell |
5,257
-63,724
| -92% | -$36M | 0.02% | 495 |
|
|
2025
Q3 | $33.5M | Buy |
68,981
+5,334
| +8% | +$2.48M | 0.21% | 107 |
|
|
2025
Q2 | $25.8M | Buy |
63,647
+2,702
| +4% | +$1.13M | 0.19% | 121 |
|
|
2025
Q1 | $30.3M | Buy |
60,945
+956
| +2% | +$518K | 0.26% | 93 |
|
|
2024
Q4 | $31.2M | Buy |
59,989
+4,426
| +8% | +$2.43M | 0.26% | 90 |
|
|
2024
Q3 | $34.4M | Buy |
55,563
+6,006
| +12% | +$3.56M | 0.31% | 81 |
|
|
2024
Q2 | $27.4M | Buy |
49,557
+5,247
| +12% | +$3.01M | 0.27% | 85 |
|
|
2024
Q1 | $25.8M | Sell |
44,310
-313
| -0.7% | -$176K | 0.29% | 86 |
|
|
2023
Q4 | $24.4M | Buy |
44,623
+10,336
| +30% | +$5M | 0.12% | 186 |
|
|
2023
Q3 | $17.4M | Buy |
34,287
+1,841
| +6% | +$981K | 0.1% | 213 |
|
|
2023
Q2 | $16.9M | Buy |
32,446
+9,725
| +43% | +$5.25M | 0.1% | 237 |
|
|
2023
Q1 | $13.1M | Sell |
22,721
-1,777
| -7% | -$1M | 0.08% | 285 |
|
|
2022
Q4 | $13.5M | Sell |
24,498
-1,131
| -4% | -$599K | 0.1% | 245 |
|
|
2022
Q3 | $13M | Buy |
25,629
+7,925
| +45% | +$4.44M | 0.1% | 206 |
|
|
2022
Q2 | $9.62M | Buy |
17,704
+2,423
| +16% | +$1.33M | 0.08% | 280 |
|
|
2022
Q1 | $9.03M | Buy |
15,281
+1,057
| +7% | +$607K | 0.06% | 307 |
|
|
2021
Q4 | $9.49M | Buy |
14,224
+1,330
| +10% | +$830K | 0.07% | 274 |
|
|
2021
Q3 | $7.37M | Sell |
12,894
-1,822
| -12% | -$1M | 0.06% | 292 |
|
|
2021
Q2 | $7.42M | Sell |
14,716
-6,258
| -30% | -$2.95M | 0.06% | 276 |
|
|
2021
Q1 | $9.57M | Buy |
20,974
+2,883
| +16% | +$1.38M | 0.1% | 212 |
|
|
2020
Q4 | $8.43M | Sell |
18,091
-298
| -2% | -$140K | 0.1% | 207 |
|
|
2020
Q3 | $8.12M | Buy |
18,389
+5,998
| +48% | +$2.48M | 0.12% | 165 |
|
|
2020
Q2 | $4.49M | Buy |
12,391
+7,505
| +154% | +$2.52M | 0.07% | 236 |
|
|
2020
Q1 | $1.39M | Buy |
4,886
+573
| +13% | +$181K | 0.03% | 406 |
|
|
2019
Q4 | $1.4M | Buy |
4,313
+419
| +11% | +$127K | 0.03% | 450 |
|
|
2019
Q3 | $1.13M | Buy |
3,894
+732
| +23% | +$210K | 0.03% | 417 |
|
|
2019
Q2 | $929K | Buy |
3,162
+1,695
| +116% | +$467K | 0.03% | 423 |
|
|
2019
Q1 | $402K | Buy |
1,467
+317
| +28% | +$78.9K | 0.03% | 395 |
|
|
2018
Q4 | $257K | Buy |
1,150
+178
| +18% | +$41.8K | 0.04% | 388 |
|
|
2018
Q3 | $237K | Buy |
+972
| New | +$224K | 0.01% | 513 |
|
Other funds holding TMO
AE Wealth Management's TMO Position: Q2 2026 in Review
AE Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 9% in Q2 2026, selling an estimated $232K and leaving 4,866 shares worth $2.44M. The position accounts for 0.01% of the portfolio, ranked #600.
AE Wealth Management first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $34.4M in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- AE Wealth Management held 4,866 shares of Thermo Fisher Scientific worth $2.44M as of Q2 2026.
- AE Wealth Management sold 484 Thermo Fisher Scientific shares in Q2 2026, an estimated $232K.
- Thermo Fisher Scientific made up 0.01% of AE Wealth Management's portfolio in Q2 2026, its #600 holding.
- AE Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
- AE Wealth Management's Thermo Fisher Scientific position peaked at $34.4M in Q3 2024.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.